(LEAD) Celltrion Q1 net income up over 3-fold on high-margin products
SEOUL, May 6 (Yonhap) -- Celltrion Inc., a major South Korean biopharmaceutical ...
ORIGINAL SOURCE →via Yonhap News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · KR
- [HEALTH] Judge who convicted South Korean ex-first lady Kim Keon Hee found dead days after ruling
- [FINANCE] Inflation expected to rise further in May due to high oil prices: BOK
- [DIPLOMACY] Seoul to hold special forum ahead of Korea-Africa foreign ministers' meeting
- [CONFLICT] PM calls for discussions on prosecution reform based on principle of no investigative rights
- [CONFLICT] Lee sends ex-lawmaker as special envoy to Costa Rican president's inauguration
- [CONFLICT] (Yonhap Interview) Grateful for chance, ex-MLB player Choi Ji-man hoping to leave impact on S. Korean club